Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6312)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2023 (publication date) through Dec 19, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Saito K, Yoza K, Takeda S, Shimoyama Y, Takeuchi K. Drug-induced entero-colitis due to interleukin-17 inhibitor use; capsule endoscopic findings and pathological characteristics: A case report. World J Gastroenterol 2023; 29(32): 4912-4919 [PMID: 37701132 DOI: 10.3748/wjg.v29.i32.4912] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Saito K, Yoza K, Takeda S, Shimoyama Y, Takeuchi K. Drug-induced entero-colitis due to interleukin-17 inhibitor use; capsule endoscopic findings and pathological characteristics: A case report. World J Gastroenterol 2023; 29(32): 4912-4919 [PMID: 37701132 DOI: 10.3748/wjg.v29.i32.4912] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i32/4912.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Natsuki Ishida, Yusuke Asai, Tomohiro Takebe, Kenichi Takahashi, Kiichi Sugiura, Tomoharu Matsuura, Kazuo Kurihara, Takahiro Suzuki, Tetsuya Honda, Ken Sugimoto. IL-17A inhibitor-induced ulcerative colitis treated with an anti-IL-23 antibody. Clinical Journal of Gastroenterology 2025; 18(4): 626 doi: 10.1007/s12328-025-02153-8
|
| 3 |
Taylor L. Spiewak, Ted A. Spiewak, Anish Patel. Ixekizumab-associated severe Crohn’s in a patient without definitive immune-mediated inflammatory disease: case report and evidence-informed guidance for non-IBD clinicians. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.1005103
|
| 4 |
Laura Mateu-Arrom, Lluis Puig. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities. Expert Review of Clinical Pharmacology 2024; 17(4): 363 doi: 10.1080/17512433.2024.2340552
|
| 5 |
Dimitrios Tsilimpotis, Georgia Kyriakou, Luc Biedermann, Stephan Vavricka, Thomas Greuter, Gerhard Rogler, Michael Doulberis. Cutaneous Manifestations and Dermatologic Adverse Events in IBD: A Clinical Update. Inflammatory Bowel Diseases 2025; doi: 10.1093/ibd/izaf228
|